论文部分内容阅读
我们对75例伤寒患者随机采用吡哌酸(PPA)、复方新诺明(SMZ-TMP)联合治疗,并与氯霉素治疗的35例作对照,现报道如下。资料与方法诊断标准:1.稽留或弛张热。2.血肥达反应阳性,并恢复期滴度升高。3.血培养检出伤寒杆菌。二组符合1、2、3项91例,符合1、2项19例。一般资料:PPA、SMZ-TMP 组(简称联台组),男21例,女54例。年龄4个月～58岁。其中有并发症者34例。氯霉素组,男16例,女19例,年龄6～58岁。药敏试验:血培养阳性的91株伤寒杆菌对氯霉素高敏占8%,低敏5.33%,不敏为86.67
We were 75 cases of typhoid patients randomized to pipemidic acid (PPA), cotrimoxazole (SMZ-TMP) combination therapy and chloramphenicol treatment of 35 cases as a control, are reported below. Materials and Methods Diagnostic criteria: 1. Retarded or remission fever. 2. Blood fat up to positive reaction, and recovery of the titers increased. 3. blood culture detected typhoid bacillus. The two groups of 91 cases conforming to 1, 2 and 3 cases, and 1 and 2 cases were 19 cases. General information: PPA, SMZ-TMP group (referred to as joint Taiwan group), 21 males and 54 females. Aged 4 months to 58 years old. There are 34 cases of complications. Chloramphenicol group, 16 males and 19 females, aged 6 to 58 years. Drug susceptibility test: blood culture-positive 91 Salmonella typhi chloramphenicol high sensitivity of 8%, low sensitivity 5.33%, insensitive to 86.67